N-PORT filing recap · January 2025
What did Polen Growth Fund buy in January 2025?
Reported stock-position changes between this filing and the previous one. These are Polen Growth Fund's own holdings, not the firm's.
Stock value
$6.48B
Positions
23
Estimated turnover
28.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Polen Growth Fund exited Novo Nordisk entirely and trimmed Amazon, Microsoft, Alphabet, and Visa. It also reduced ServiceNow, Netflix, and Gartner substantially, while adding to Oracle and CoStar Group. The most notable increase was Eli Lilly, which it added to dramatically, along with a substantial boost to Zoetis.